CSIMarket
 


Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

LH's Revenue Growth by Quarter and Year

Laboratory Of America Holdings's Revenue results by quarter and year




LH Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 2,953.40 2,787.50 2,655.20
III Quarter September 3,896.10 2,928.50 2,831.30 2,542.90
II Quarter June 2,768.80 2,881.70 2,866.30 2,447.00
I Quarter March 2,823.80 2,791.20 2,848.30 2,414.70
FY   9,488.70 11,554.80 11,333.40 10,059.80



LH Revenue third quarter 2020 Y/Y Growth Comment
Laboratory Corporation Of America Holdings achieved in the third quarter, above Company average Revenue growth of 33.04% year on year, to $ 3,896.10 millions.

Looking into third quarter results within Medical Laboratories industry 9 other companies have achieved higher Revenue growth. While Laboratory Corporation Of America Holdings' s Revenue rise of 33.04% ranks overall at the positon no. 599 in the third quarter.




LH Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - 5.95 % 4.98 % 9.24 %
III Quarter September 33.04 % 3.43 % 11.34 % 7.39 %
II Quarter June -3.92 % 0.54 % 17.14 % 5.6 %
I Quarter March 1.17 % -2 % 17.96 % 6.42 %
FY   - 1.95 % 12.66 % 7.19 %

Financial Statements
Laboratory Of America Holdings's third quarter 2020 Revenue $ 3,896.10 millions LH's Income Statement
Laboratory Of America Holdings's third quarter 2019 Revenue $ 2,928.50 millions Quarterly LH's Income Statement
New: More LH's historic Revenue Growth >>


LH Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 0.85 % -1.55 % 4.42 %
III Quarter September 40.71 % 1.62 % -1.22 % 3.92 %
II Quarter June -1.95 % 3.24 % 0.63 % 1.34 %
I Quarter March -4.39 % 0.13 % 7.27 % -0.66 %
FY (Year on Year)   - 1.95 % 12.66 % 7.19 %




Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #167
Overall #599

Revenue Y/Y Growth Statistics
High Average Low
49.64 % 9.06 % -3.92 %
(Jun 30 2015)   (Jun 30 2020)
Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #167
Overall #599
Revenue Y/Y Growth Statistics
High Average Low
49.64 % 9.06 % -3.92 %
(Jun 30 2015)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Laboratory Of America Holdings's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
40.71 % 2.81 % -4.39 %
(Sep 30 2020)  


LH's III. Quarter Q/Q Revenue Comment
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2020 above company average sequential Revenue jump of 40.71%, to $ 3,896.10 millions, from $2,768.80 millions in the second quarter.
Medical Laboratories company is going from strength to strength, not just recording above normal growth, and also increasing speed.

Within Medical Laboratories industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Laboratory Of America Holdings's Revenue growth quarter on quarter, overall rank is 769.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #14
Healthcare Sector #190
Overall #769
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #14
Healthcare Sector #190
Overall #769
Revenue Q/Q Growth Statistics
High Average Low
40.71 % 2.81 % -4.39 %
(Sep 30 2020)  


LH's III. Quarter Q/Q Revenue Comment
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2020 above company average sequential Revenue jump of 40.71%, to $ 3,896.10 millions, from $2,768.80 millions in the second quarter.
LH is impressively improving, not just claiming above average gain, and additionally improving speed, Tyler  W. Jackson, an industry expert from Edinburgh said.

Within Medical Laboratories industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Laboratory Of America Holdings's Revenue growth quarter on quarter, overall rank is 769.


Laboratory Of America Holdings's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Revenue 12 Months Ending $ 12,442.10 $ 11,474.50 $ 11,587.40 $ 11,554.80 $ 11,388.90
Y / Y Revenue Growth (TTM) 9.25 % 1.62 % 2.76 % 1.95 % 1.68 %
Year on Year Revenue Growth Overall Ranking # 212 # 399 # 972 # 1022 # 1861
Seqeuential Revenue Change (TTM) 8.43 % -0.97 % 0.28 % 1.46 % 0.86 %
Seq. Revenue Growth (TTM) Overall Ranking # 520 # 1655 # 956 # 2333 # 1088




Cumulative Revenue growth Comment
Although Laboratory Of America Holdings's Annual Revenue growth year on year were below company's average 9.89% , Revenue announced in the Sep 30 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 9.25% year on year, from 1.62% in Jun 30 2020.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 212, from total ranking in previous quarter at 399.

Revenue TTM Q/Q Growth Statistics
High Average Low
11.05 %
1.69 %
-29.4 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 28
Overall # 212

Revenue TTM Y/Y Growth Statistics
High Average Low
47.24 %
9.89 %
1.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 146
S&P 500 # 520
Cumulative Revenue growth Comment
Although Laboratory Of America Holdings's Annual Revenue growth year on year were below company's average 9.89% , Revenue announced in the Sep 30 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 9.25% year on year, from 1.62% in Jun 30 2020.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 212, from total ranking in previous quarter at 399.

Revenue TTM Q/Q Growth Statistics
High Average Low
11.05 %
1.69 %
-29.4 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 28
Overall # 212

Revenue TTM Y/Y Growth Statistics
High Average Low
47.24 %
9.89 %
1.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 146
S&P 500 # 520




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LH's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LH's Competitors
Revenue Growth for Laboratory Of America Holdings's Suppliers
Revenue Growth for LH's Customers

You may also want to know
LH's Annual Growth Rates LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2020
Salarius Pharmaceuticals inc   57.52 %$ 57.522 millions
Guardion Health Sciences Inc   57.10 %$ 57.102 millions
Organogenesis Holdings Inc   56.85 %$ 56.849 millions
Cormedix Inc   56.26 %$ 56.257 millions
Vaccinex Inc   54.70 %$ 54.703 millions
Resmed Inc   54.65 %$ 54.649 millions
Albireo Pharma inc   53.86 %$ 53.863 millions
Kala Pharmaceuticals inc   53.00 %$ 52.998 millions
Casi Pharmaceuticals Inc   52.21 %$ 52.207 millions
Abbvie Inc   52.16 %$ 52.164 millions
Chf Solutions Inc   52.08 %$ 52.077 millions
Supernus Pharmaceuticals inc   51.88 %$ 51.885 millions
Precision Biosciences Inc  51.35 %$ 51.346 millions
Amneal Pharmaceuticals Inc   51.15 %$ 51.150 millions
Collegium Pharmaceutical inc   51.02 %$ 51.023 millions
Gw Pharmaceuticals Plc  50.66 %$ 50.656 millions
Fluidigm Corp  50.44 %$ 50.442 millions
Nanovibronix Inc   48.51 %$ 48.515 millions
Sanara Medtech Inc   48.02 %$ 48.020 millions
Aclaris Therapeutics Inc   47.41 %$ 47.406 millions
Theravance Biopharma inc   46.91 %$ 46.914 millions
Sarepta Therapeutics Inc   45.32 %$ 45.318 millions
Sutro Biopharma Inc   45.17 %$ 45.174 millions
Viveve Medical Inc   44.87 %$ 44.867 millions
Adamas Pharmaceuticals Inc  44.81 %$ 44.807 millions
Infinity Pharmaceuticals Inc   44.61 %$ 44.606 millions
Novocure Limited  44.10 %$ 44.099 millions
Quest Diagnostics Inc  42.43 %$ 42.434 millions
Adma Biologics Inc   42.28 %$ 42.283 millions
Viemed Healthcare Inc   42.18 %$ 42.176 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SCWX's Profile

Stock Price

SCWX's Financials

Business Description

Fundamentals

Charts & Quotes

SCWX's News

Suppliers

SCWX's Competitors

Customers & Markets

Economic Indicators

SCWX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071